Form 8-K Retrophin, Inc. For: Feb 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Retrophin (RTRX) Reports Q4 Loss of $0.36
March 5, 2015 4:17 PM ESTRetrophin (NASDAQ: RTRX) reported Q4 EPS of ($0.36), versus ($0.46) reported last year. Revenue for the quarter came in at $14.1 million, versus $0 reported last year.
For earnings history and earnings-related data on Retrophin (RTRX) click here.
... MoreRetrophin (RTRX) Receives Nasdaq 'Letter of Reprimand'
March 3, 2015 6:22 AM ESTRetrophin (NASDAQ: RTRX) disclosed the following today:
Item 3.01Notice of Delisting or Failure to Satisfy a Continued Listing Rule or... More


